Alveo Technology | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Alveo Technologies is a California-based diagnostics company founded in 2014, specializing in decentralized molecular testing platforms for rapid pathogen detection in human, animal, and environmental health. Headquartered in Alameda, the company develops low-cost, user-friendly diagnostic solutions aimed at transforming infectious disease detection and management. With a focus on early detection, Alveo enables faster decision-making for individuals, healthcare providers, and industries such as poultry farming.

The company's core technology, the be.well platform, integrates sample preparation, nucleic acid amplification, and real-time detection into a compact analyzer. This platform supports a variety of pathogens and provides results in under an hour. Initial applications target acute respiratory infections, including COVID-19 and influenza, as well as avian influenza in poultry. The company collaborates with veterinary experts and aims to expand its testing capabilities to address broader public health threats.